(AW) Conference Coverage (Palm Springs Symposium): Chiron's Sindbis Plasmid Outperforms Conventional DNA

DonateNow
Print this article

(AW) Conference Coverage (Palm Springs Symposium): Chiron's Sindbis Plasmid Outperforms Conventional DNA

AIDSWEEKLY Plus; Monday, April 6, 1998
Daniel J. DeNoon, Senior Editor


New alphavirus plasmids deliver genomic packages more efficiently than conventional DNA plasmids.

The novel plasmids have successfully delivered DNA encoding HIV or herpes simplex antigens in the mouse model, reported Douglas Jolly of Chiron Technologies, San Diego, California.

"For considerably less DNA you get more bang for your DNA buck," Jolly said in a presentation to the workshop "Virus Vectors for AIDS Vaccines" sponsored by the Division of AIDS, National Institute of Allergy and Infectious Diseases, held March 4, 1998, in Palm Springs, California, in association with the 1998 Palm Springs Symposium on HIV/AIDS.

He noted that the vectors, based on Sindbis virus, yield 30- to 100-fold more potent responses than more conventional DNA vectors. In mouse experiments, a plasmid encoding the herpes simplex glycoprotein B elicited significant immune responses at doses as low as 10 nanograms.

A report on these experiments recently appeared in the Journal of Virology ("DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector," Hariharan, M.J. et al., J Virol, 1998;72(2):950--8).

Jolly said his laboratory currently is working to determine the dosage needed to elicit immune responses in monkeys.

"If we could do this in primates, it would really be interesting," he speculated.


980406
AW980403


Copyright © 1998 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA.

Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsfile.com

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .